DNA Stock Analysis: Buy, Sell, or Hold?
DNA - Ginkgo Bioworks Holdings, Inc.
$7.40
0.44 (6.32%)
â˛
5d:
+8.98%
30d:
-6.68%
90d:
-8.42%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When DNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: DNA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: DNA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: DNA is currently trading at $7.40, which is considered slightly low relative to its 30-day fair value range of $7.14 to $8.65.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $6.47, while resistance sits at $8.27. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNA is in a strong uptrend. Immediate support is located at $6.47, while resistance sits at $8.27. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$7.14 -
$8.65
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
Protect Your Profits
Holding DNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (51/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BEARISH: Trading above Wall St target ($7.00)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.14 -
$8.65
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.47
Resistance Level
$8.27
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.55
Wall Street Target
$7.00
(-5.4%)
Revenue Growth (YoY)
-48.5%
Profit Margin
-219.6%
Share & Embed Analysis
Last updated: August 24, 2026 1:28 AM ET
Data refreshes hourly during market hours. Next update: 2:28 AM
Data refreshes hourly during market hours. Next update: 2:28 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Steven P Coen
SELL
324 shares
2026-04-17
Steven P Coen
SELL
33171 shares
2026-04-13
Barry Canton
SELL
124727 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
Advanced DNA Option Strategies
Professional options setups generated by AI based on today's DNA price and gamma walls.
